BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 18021759)

  • 1. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
    Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
    Neuropharmacology; 2004 Dec; 47(8):1170-9. PubMed ID: 15567426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
    Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
    Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to marijuana smoke impairs memory retrieval in mice.
    Niyuhire F; Varvel SA; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1067-75. PubMed ID: 17586723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus.
    Cluny NL; Naylor RJ; Whittle BA; Javid FA
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):150-6. PubMed ID: 18816298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
    Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
    Wise LE; Thorpe AJ; Lichtman AH
    Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
    Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
    Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
    Rodrigues LC; Conti CL; Nakamura-Palacios EM
    Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells.
    Heyser CJ; Hampson RE; Deadwyler SA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):294-307. PubMed ID: 8380864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats.
    Egashira N; Manome N; Kurauchi K; Matsumoto Y; Iwasaki K; Mishima K; Shoyama Y; Fujiwara M
    Phytother Res; 2007 Feb; 21(2):126-9. PubMed ID: 17117451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts.
    Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
    Behav Brain Res; 2006 Apr; 168(2):307-11. PubMed ID: 16406104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
    Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
    Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
    Malone DT; Jongejan D; Taylor DA
    Pharmacol Biochem Behav; 2009 Aug; 93(2):91-6. PubMed ID: 19393686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
    Gomes FV; Del Bel EA; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
    Zuardi AW; Teixeira NA; Karniol IC
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.
    Ashton JC; Smith PF; Darlington CL
    Pharmacology; 2008; 81(1):18-20. PubMed ID: 17726344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.